Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Geoffrey Duyk Insider Profile
4 Followers
Geoffrey Duyk, Director at Aerie Pharma, holds 23.40K shares in Amyris (Ticker: AMRS), holds 1.70K shares in Aerie Pharma (Ticker: AERI), holds 0.00 shares in Cardiovascular Systems (Ticker: CSII).
Geoffrey Duyk has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Geoffrey Duyk holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Geoffrey Duyk
Geoffrey Duyk's Trading History
Aerie Pharma
Feb 16, 2017
Director
Uninformative Sell
2.72M
$22.10K
Amyris
Aug 07, 2020
Director
Uninformative Buy
―
$68.32K
Cardiovascular Systems
―
Former Director (1)
―
$0.00
Epirus Biopharma
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Geoffrey Duyk's performance on stock
You May Also Like
Geoffrey Duyk insider profile FAQ
What is the percentage of profitable transactions made by Geoffrey Duyk?
The percentage of profitable transactions made by Geoffrey Duyk is ―.
What is the average return per transaction made by Geoffrey Duyk?
The average return per transaction made by Geoffrey Duyk is ―.
What stocks does Geoffrey Duyk hold?
Geoffrey Duyk holds: AERI, AMRS, CSII, EPRSQ stocks.
What was Geoffrey Duyk’s latest transaction?
Geoffrey Duyk latest transaction was an Uninformative Buy of ―.
What was Geoffrey Duyk's most profitable transaction?
Geoffrey Duyk’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Geoffrey Duyk's role in Aerie Pharma?
Geoffrey Duyk's role in Aerie Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.